![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_86630ba4a7e4889b44175ac812cce53f.svg) | Nicotine | IC50 | 427.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_86630ba4a7e4889b44175ac812cce53f.svg) | Nicotine | Ki | 1.05 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_f4b1d136c22b35f47b0361ed8a5f8191.svg) | Varenicline | IC50 | 39.0 [1], 70.0 [2], 94.0 [3], 50000.0 [4] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_361ebe418f7f23487e23bc76f4bafd5f.svg) | Epibatidine | IC50 | 1.06 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_361ebe418f7f23487e23bc76f4bafd5f.svg) | Epibatidine | Ki | 0.07 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_0f419d3719cf510be57b9e88deebdfd6.svg) | Sazetidine A | IC50 | 4.8 [1], 7.5 [2], 11.0 [3] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_0f419d3719cf510be57b9e88deebdfd6.svg) | Sazetidine A | Ki | 0.06 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_6da87654a41806f746deff10f04e816a.svg) | Cytisine | IC50 | 50.0 [1], 28000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_6da87654a41806f746deff10f04e816a.svg) | Cytisine | Ki | 0.23 [1], 2.0 [2], 2.59 [3] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_eb3d09dc810ce26e1e75e749a40ec201.svg) | (S)-3-(Azetidin-2-ylmethoxy)pyridine | IC50 | 1.51 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_eb3d09dc810ce26e1e75e749a40ec201.svg) | (S)-3-(Azetidin-2-ylmethoxy)pyridine | Ki | 0.04 [1], 0.05 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_fcd3cfefde2b46eddadc801088ffc22a.svg) | Bupropion | IC50 | 12.0 [1], 12000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_e390c4c573e564388f9de32c52989fa9.svg) | Dihydro-beta-erythroidine | IC50 | 20.0 [1], 410.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_e390c4c573e564388f9de32c52989fa9.svg) | Dihydro-beta-erythroidine | Ki | 98.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_4683d32662dfbc19eebe5b3861da797e.svg) | N,N-Dimethyl-2-(pyridin-3-yloxy)ethanamine | Ki | 21.0 [1], 300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_93dedeb198ac0ca5933ecbe2847cfca3.svg) | Dimethyl-pyridin-3-ylmethyl-amine | Ki | 540.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_e092fcee83423081f5bf6eb16833f8d4.svg) | N-Methyl-4-(pyridin-3-yl)but-3-yn-1-amine | Ki | 58.0 [1], 113.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_43a42f1a2bf1d191fa51bbfaa26ba7e3.svg) | 3-[(2s)-Azetidin-2-Ylmethoxy]-5-[(1s,2r)-2-(2-Methoxyethyl)cyclopropyl]pyridine | IC50 | 5.6 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_b71ce768bf8820406b32aa670d522ec0.svg) | 3-[[(2S)-Azetidin-2-yl]methoxy]-5-hex-1-ynyl-2-methylpyridine | IC50 | 18.0 [1], 260.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_b71ce768bf8820406b32aa670d522ec0.svg) | 3-[[(2S)-Azetidin-2-yl]methoxy]-5-hex-1-ynyl-2-methylpyridine | Ki | 12.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_5b0e905c59f86ce8bb86f67e7c0a924d.svg) | 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(6-fluorohex-1-ynyl)-2-methylpyridine | IC50 | 130.0 [1], 140.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_5b0e905c59f86ce8bb86f67e7c0a924d.svg) | 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(6-fluorohex-1-ynyl)-2-methylpyridine | Ki | 4.2 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_1cb46d8ec1fd3e361ebd39de1eb91d97.svg) | 6-[5-[[(2S)-Azetidin-2-yl]methoxy]-6-methylpyridin-3-yl]hex-5-yn-1-ol | IC50 | 42.0 [1], 51.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_1cb46d8ec1fd3e361ebd39de1eb91d97.svg) | 6-[5-[[(2S)-Azetidin-2-yl]methoxy]-6-methylpyridin-3-yl]hex-5-yn-1-ol | Ki | 4.3 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_81138852c1ddf35c386e671d5d8b533b.svg) | 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(6-chlorohex-1-ynyl)-2-methylpyridine | IC50 | 260.0 [1], 270.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_81138852c1ddf35c386e671d5d8b533b.svg) | 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(6-chlorohex-1-ynyl)-2-methylpyridine | Ki | 4.7 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_891886f6dbb36cd12981ddbd4e3d45d4.svg) | 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(2-cyclopropylethynyl)-2-methylpyridine | IC50 | 11.0 [1], 110.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_891886f6dbb36cd12981ddbd4e3d45d4.svg) | 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(2-cyclopropylethynyl)-2-methylpyridine | Ki | 9.6 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_4790c2ed4aa68637e502beb23ab8d1bb.svg) | 5-Hex-1-ynyl-2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine | IC50 | 1600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_4790c2ed4aa68637e502beb23ab8d1bb.svg) | 5-Hex-1-ynyl-2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine | Ki | 73.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_2ac158b6eae5a9f72dbda0492988dc93.svg) | [1-[(3-Hydroxyphenyl)methyl]indol-3-yl]methyl-trimethylazanium | IC50 | 14700.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_2ac158b6eae5a9f72dbda0492988dc93.svg) | [1-[(3-Hydroxyphenyl)methyl]indol-3-yl]methyl-trimethylazanium | Ki | 1600.0 [1], 112000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_04cbfb18d4637aa7607c73b2f21de570.svg) | Ondansetron | IC50 | 66000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_04cbfb18d4637aa7607c73b2f21de570.svg) | Ondansetron | Ki | 46000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_9bf567bfce4fef60f82160d0177552b0.svg) | 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine | IC50 | 94.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_9bf567bfce4fef60f82160d0177552b0.svg) | 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine | Ki | 0.12 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_fe503d49f756ee0177fb46d02c8c9aca.svg) | Tropisetron | IC50 | 170000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_fe503d49f756ee0177fb46d02c8c9aca.svg) | Tropisetron | Ki | 55000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_0c1366b4ba2cc7716b67fbabafb2d739.svg) | (+)-Epibatidine | Ki | 0.03 [1], 0.04 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_b816190d3453ae51305cb18904d5e71a.svg) | Lobelin | Ki | 4.0 [1], 5.01 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_889c75941cc4ae0a55b6d028f9169fbd.svg) | alpha-Methyltryptamine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_45d6e90fcd2b7827bf0fea3f667ce1eb.svg) | Rivanicline | Ki | 25.0 [1], 26.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_bcda24337f1f48f0e0f78a4fd27d888e.svg) | Radafaxine | IC50 | 20000.0 [1], 31000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_7e67dc53b9dda9b460fb3afbfa5076d7.svg) | N,N-Diallyl-5-methoxytryptamine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_d69862a45532fac2b6e0b067c9eea0cd.svg) | 5-(6-Chloro-3-pyridinyl)-9-azabicyclo[4.2.1]non-4-ene | Ki | 0.04 [1], 0.27 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_3c57e2725863f26a6d26d4591478a16d.svg) | N-(2-Fluorophenyl)-2-{4-[(4-fluorophenyl)sulfonyl]piperazin-1-yl}acetamide | IC50 | 9300.0 [1], 9800.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_2e26e937595d1d74af917941221ea472.svg) | 2-(3-Pyridyl)-1,4-ethanopiperidine | Ki | 1.0 [1], 2.9 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_0a857010cf06d49165eb935f62cf08b0.svg) | 3-(5-Chloro-2-furoyl)-3,7-diazabicyclo[3.3.0]octane | Ki | 30.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_989d6c79f55e456b9790ad8f1d927895.svg) | 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(2-phenylethynyl)pyridine | IC50 | 16.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_989d6c79f55e456b9790ad8f1d927895.svg) | 3-[[(2S)-Azetidin-2-yl]methoxy]-5-(2-phenylethynyl)pyridine | Ki | 0.05 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_068b477c23efb492bfdfb5c535e057fa.svg) | N-Methyl-1-(pyridin-3-yl)methanamine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_30aaca89f5eafacdae70361bd79cde21.svg) | (1R,2R,4S)-2-(6-Chloropyridin-3-yl)-7-methyl-7-azabicyclo[2.2.1]heptane | Ki | 0.04 [1], 0.26 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_627c8508e14d46439eb812a8d4daaefd.svg) | Erysotrine | Ki | 600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_1cdb19f18f59b42d1c8ae5ebc29278b5.svg) | 3-(N-Ethyl-N-methylaminomethyl)pyridine | Ki | 28.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_05e386909f703bcc3f04172f71d0c2e1.svg) | N-Methyl-2-(pyridin-3-yloxy)ethanamine | Ki | 35.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_69aaca6fe3f6c1e2f13a552e8b74d084.svg) | 3-[(Z)-(3-Pyridyl)methylene]-1-azabicyclo[2.2.2]octane | Ki | 2.0 [1], 6.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_7850fef27a68ad56733373b5a624143f.svg) | Trimethyl(2-pyridin-3-yloxyethyl)azanium | Ki | 0.5 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_438220d42319e0ffca8be5b2625d1f41.svg) | 3-(3-Pyridinyl)-3,7-diazabicyclo[3.3.1]nonane | Ki | 0.1 [1], 0.2 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_c378772c0bb0db71ed12902503a5765f.svg) | Cyclopropyl(3,7-diazabicyclo[3.3.1]nonan-3-yl)methanone | Ki | 1.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_f1e8c0ee2b67027176c81ab71af7983e.svg) | 2,3,3a,4,6,6a-Hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl(cyclopropyl)methanone | Ki | 4.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_71387e3648dae3be19198b1b82aa8ffa.svg) | N-[(2R,3R)-2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide | Ki | 157.0 [1], 10000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_0ea738f2fc632beaeaaeab046324aadf.svg) | N,N-Dimethyl-4-(pyridin-3-yl)but-3-yn-1-amine | Ki | 510.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_a5bbbd13b7dbf6a21f5571bad8ed86e8.svg) | N-Ethyl-N-methyl-4-(pyridin-3-yl)but-3-yn-1-amine | Ki | 1770.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_33019aa9e472c1f0bc17685ebde1b1ad.svg) | (2S,3S)-2-(3-Fluorophenyl)-3,5,5-trimethylmorpholin-2-ol | IC50 | 1300.0 [1], 23000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_6dd539c533459c86589f0bbeec6cfa06.svg) | (2S,3S)-2-(3-Bromophenyl)-3,5,5-trimethylmorpholin-2-ol | IC50 | 550.0 [1], 12000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_f11f6184d360532feea2f8f0457b1f36.svg) | (2S,3S)-2-(3-Chlorophenyl)-3-ethyl-5,5-dimethylmorpholin-2-ol | IC50 | 2900.0 [1], 14000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_23a9fa7714ff1998e5d0500d5cfb3008.svg) | (2S,3S)-2-(3-Chlorophenyl)-5,5-dimethyl-3-propyl-morpholin-2-ol | IC50 | 7500.0 [1], 9500.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_c136e181d6441da4465a5f56ff5542e3.svg) | (2S,3S)-2-(3-Chlorophenyl)-3,4,5,5-tetramethylmorpholin-2-ol | IC50 | 7100.0 [1], 16000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_079260af629afc451893d6f294a5fc46.svg) | (R,R)-Hydroxy Bupropion | IC50 | 3300.0 [1], 17000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_fc5169e3016de93e61f5cd4b0f948a56.svg) | 3-Butyl-5-((S)-1-methyl-pyrrolidin-2-ylmethoxy)-pyridine | IC50 | 640.0 [1], 5000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_06f806eea2aab8da4d4c57363fb57b72.svg) | 3-((S)-1-Methyl-pyrrolidin-2-ylmethoxy)-5-propyl-pyridine | IC50 | 2400.0 [1], 3200.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_6d8fdeab3a9666c2b9c920d1578c5cc3.svg) | 5-[(1R,2S,4R)-7-Azabicyclo[2.2.1]heptan-2-yl]-3-methyl-1,2-oxazole | Ki | 0.46 [1], 1.33 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_6a930c012f4d7a79f4880b20e1cae363.svg) | [(1r,5s)-8-Phenethyl-8-Azabicyclo[3.2.1]octan-3-Yl] Benzoate | Ki | 31622.78 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_f3897a3f4152cd311f22656833931d9b.svg) | [(1S,5R)-8-[2-(3,5-Dihydroxyphenyl)-2-hydroxyethyl]-8-azabicyclo[3.2.1]octan-3-yl] benzoate | Ki | 31622.78 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_2079dd9e35965d80fe3c86c9a7a9c8a4.svg) | 2,3,3a,4,6,6a-Hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl-(4-phenoxyphenyl)methanone | IC50 | 7800.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_2079dd9e35965d80fe3c86c9a7a9c8a4.svg) | 2,3,3a,4,6,6a-Hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl-(4-phenoxyphenyl)methanone | Ki | 19.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_aee0e3979d4a31710b664da5195ff034.svg) | 4-Chlorobenzoic acid [(2S)-1-methylpyrrolidine-2-yl]methyl ester | IC50 | 3600.0 [1], 95000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_232a748a95068f92e7ec3d962d51b095.svg) | 4-(Benzyloxy)benzoic acid [(2S)-1-methylpyrrolidine-2-yl]methyl ester | IC50 | 3600.0 [1], 25800.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_828326e039c8fb47329a46e9e2dec1fc.svg) | Benzoic acid [(2S)-1-methylpyrrolidine-2-yl]methyl ester | IC50 | 2500.0 [1], 313000.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_894c2cd57e46cef4e3e16277dc1783d0.svg) | 3-Aminobenzoic acid [(2S)-1-methylpyrrolidine-2-yl]methyl ester | IC50 | 1020.0 [1], 4300.0 [2] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_bbae101873f02db95327d174bef24719.svg) | 1-Decyl-3-((S)-1-methyl-pyrrolidin-2-yl)-pyridinium; iodide | IC50 | 200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_bbae101873f02db95327d174bef24719.svg) | 1-Decyl-3-((S)-1-methyl-pyrrolidin-2-yl)-pyridinium; iodide | Ki | 0.09 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_2bafbf6fa1d27571140cfe3409d3d797.svg) | [1-[(4-Hydroxyphenyl)methyl]indol-3-yl]methyl-trimethylazanium | IC50 | 24900.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_2bafbf6fa1d27571140cfe3409d3d797.svg) | [1-[(4-Hydroxyphenyl)methyl]indol-3-yl]methyl-trimethylazanium | Ki | 600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_e20e2a74fed1971c04bdb8f566c19888.svg) | Carbastat | Ki | 750.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_f36665d48cf053dc7e38624549f06881.svg) | Tubocurarine chloride | IC50 | 9200.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_b9a73af7b9c5977535db0228e5a4eeb8.svg) | Mecamylamine | IC50 | 600.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_9c899a99710c07e1519d4a15cce837c2.svg) | Imidacloprid | Ki | 720.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_9c3656ff341e5e268acece6a306b8bb8.svg) | Granisetron | Ki | 38000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_2cb3539cbcab54cd61d20691715b1d3e.svg) | Tetramethylammonium | Ki | 24.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_dd425d6179d33d0ef222752999ad8842.svg) | 1-(9-Azabicyclo[4.2.1]non-4-en-5-yl)ethanone | Ki | 1.1 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_0ca75bcf4405c6fffdd846e6b342f09d.svg) | Lobeline | Ki | 5.01 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_ff3ecb393cefca2925d95c4ad64fed55.svg) | 3-(Piperidin-2-yl)pyridine | Ki | 92.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_61ebe959f75818058f67ff1564840977.svg) | Anatoxin A | Ki | 0.34 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_b76189cabac5b949a1d3108e5ba7e808.svg) | Methyllycaconitine | Ki | 10000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_ff50863ed8622640c38cee1152de8e90.svg) | Boldine | Ki | 3000.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_3c1d5014b33e81c690cba4f30cd9fe6e.svg) | Nornicotine | Ki | 29.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_d7e372c4785415c85ac635995434e70b.svg) | 3-(2,4-Dimethoxybenzylidene)anabaseine | Ki | 51.0 [1] |
![](https://images.aatbio.com/dataset/ic50/neuronal-acetylcholine-receptor-alpha4-beta2_f4447b2edb88e5ef4694b6b26776dda0.svg) | Polygodial | IC50 | 62500.0 [1] |